Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Finetest Lite Smart Blood Glucose Monitoring System

K-Number: K201396 · 2020-10-16

ApplicantOsang Healthcare Co. , Ltd.
Decision Date2020-10-16
Product CodeNBW
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Finetest Lite Smart Blood Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Osang Healthcare Co. , Ltd.. It received FDA 510(k) clearance on 2020-10-16 under 510(k) number K201396. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Finetest Lite Smart Blood Glucose Monitoring System?

Finetest Lite Smart Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2020-10-16. The listed applicant is Osang Healthcare Co. , Ltd.. The 510(k) number is K201396.

When did Finetest Lite Smart Blood Glucose Monitoring System receive FDA 510(k) clearance?

Finetest Lite Smart Blood Glucose Monitoring System received FDA 510(k) clearance on 2020-10-16, under 510(k) number K201396.

Who is the listed applicant for Finetest Lite Smart Blood Glucose Monitoring System?

The FDA 510(k) record lists Osang Healthcare Co. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Finetest Lite Smart Blood Glucose Monitoring System?

The FDA product code for Finetest Lite Smart Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT06657183ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving ChemotherapyCOMPLETEDNCT07595289DP-DCT 1.0：A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT PlatformNOT_YET_RECRUITING

Other records listing Osang Healthcare Co. , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K203562Finetest Lite Blood Glucose Monitoring SystemK182286Oh'Care Lite Smart Blood Glucose Monitoring System

Related Devices (Code: NBW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262116TRUE METRIX Self Monitoring Blood Glucose SystemTrividia Health, Inc.K250085On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring SystemACON Laboratories, Inc.K243060TeleRPM Gen2 Blood Glucose Monitoring SystemGuangdong Transtek Medical Electronics Co., Ltd.K240637RIGHTEST Blood Glucose Monitoring System Max TelBionime CorporationK240640Sejoy Blood Glucose Monitoring System; Sejoy Advance Link Blood Glucose Monitoring SystemSejoy Biomedical Co., Ltd.K241787CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑